TRACON Pharmaceuticals, Inc. (NASDAQ:TCON) Posted Basic Consolidated EPS Of $-2.1959

0

TRACON Pharmaceuticals, Inc. (NASDAQ:TCON) annual basic consolidated EPS was $-2.1959 for the period ended 2015-12-31. The basic consolidated EPS was $-2.1959 for the quarter ended 2015-12-31.

EPS from continuing operations

TRACON Pharmaceuticals, Inc. (NASDAQ:TCON)’s basic EPS from continuing operations was $-2.1959 for the fiscal year 2015-12-31. For the quarter ended 2015-12-31 it stood at $-2.1959

EPS contribution from parent

From the parent company TRACON Pharmaceuticals, Inc. (NASDAQ:TCON) posted basic EPS of $-2.1959 for the fiscal ended 2015-12-31. For the quarter that ended on 2015-12-31 the figure stood at $-2.1959.

Basic net EPS

The Basic net EPS of TRACON Pharmaceuticals, Inc. (NASDAQ:TCON) was $-2.2 for the period ended 2015-12-31. The figure stood at $-2.2 for the quarter that ended 2015-12-31.

Consolidated diluted EPS

The consolidated diluted EPS for the fiscal year 2015-12-31 stood at $-2.1959. While the figure for the quarter ended 2015-12-31 stood at $-2.1959.

Basic diluted EPS

The diluted EPS from continuing operation of TRACON Pharmaceuticals, Inc. (NASDAQ:TCON) stood at $-2.1959 for the fiscal 2015-12-31. The figure for the quarter ended 2015-12-31 stood at $-2.1959

Net diluted EPS

The Net diluted EPS was $-2.2 for the fiscal 2015-12-31. The figure for the quarter ended 2015-12-31 stood at $-2.2.

Diluted EPS from parent

TRACON Pharmaceuticals, Inc. (NASDAQ:TCON) diluted EPS from the parent company for the fiscal 2015-12-31 was $-2.1959. The figure for the quarter ended 2015-12-31 was $-2.1959

The net basic EPS was $-2.2 for fiscal 2015-12-31. The figure for the quarter ended 2015-12-31 was $-2.2

1 Chart Pattern Every Investor Should Know

This little-known pattern preceded moves of 578% in ARWR, 562% in LCI, 513% in ICPT, 439% in EGRX, 408% in ADDUS and more...

Click Here to See This Now.

(Visited 7 times, 1 visits today)